Holen Sie sich die Stockscreener-App
1.01
5.61%
-0.06
Handel nachbörslich:
.99
-0.02
-1.98%
Finanzdaten der Tvardi Therapeutics Inc-Aktie (TVRD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
5.98%
6.629
|
7.051 | 7.587 | 5.938 | 8.869 |
| Operating Income/Loss |
5.98%
-6.629
|
-7.051 | -7.587 | -5.938 | -8.869 |
| Income Tax Expense/Benefit, Current |
-
|
- | - | - | - |
| Income Tax Expense/Benefit, Deferred |
-
|
- | - | - | - |
Net Income/Loss
|
5.10%
-6.457
|
-6.804 | -7.275 | -5.527 | 4.167 |
| Basic Average Shares |
0.00%
9.3813
|
9.3813 | - | 9.3771 | 8.2466 |
| Diluted Average Shares |
0.00%
9.3813
|
9.3813 | - | 9.3771 | 8.4552 |
| Basic Earnings Per Share |
5.48%
-0.69
|
-0.73 | - | -0.59 | 0.51 |
| Diluted Earnings Per Share |
5.48%
-0.69
|
-0.73 | - | -0.59 | -1.00 |
| Common Stock Dividends |
-
|
- | - | - | - |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):